CeQur
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Switzerland · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Ebenaustrasse 10, Horw, Lucerne, 6048, S...Phone Number
+41 415004862Website
www.myceqursimplicity.comRevenue
$51.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About CeQur
CeQur is commercializing advanced, simple-to-use insulin-delivery devices that make it easier for people living with diabetes to adhere to therapy and stay in control of their disease. Established in 2008, CeQur is headquartered in Switzerland.Explore more
CeQur Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CeQur your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if CeQur is spiking on competitors!
Product Launch: Get notified when CeQur launches new products
Click to see if CeQur had a recent Job posting/layoffs
CeQur, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once CeQur has new funding data
Check if CeQur has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at CeQur
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on CeQur recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at CeQur
Find 3 more new buyers
Company Profile Activity
Activity Insights
CeQur is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CeQur is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CeQur.
CeQur financials insights
Gather financial insights about CeQur, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2010
Series A
$29.6M
2013
Series B
$27M
2015
Series C
$215M
2025
Private Equity
$120M
CeQur Tech Stack
A closer look at the technologies used by CeQur
Most Recent Scoops
Project
, according to a high-level source in advertising & promotion, is in the midst of initiatives related to public relations. The organization is currently evaluating Edelman and Oglivy.
Advertising, Public Relations
Project
, according to a high-level source in advertising & promotion, is in the midst of initiatives related to content marketing. The organization is currently evaluating various vendors.
Advertising, Content Management, Marketing Operations
Project
, according to a high-level source in advertising & promotion, is planning to begin initiatives related to video marketing within six to nine months.
Digital Marketing, Advertising, Video
Project
, according to a high-level source in advertising & promotion, is in the midst of initiatives related to email marketing. The organization is currently evaluating Constant Contact, Mailchimp, and Salesforce Email Studio.
Digital Marketing, Advertising, Sales, Email, Messaging, Marketing Operations
Project
Advertising, Print Advertising
CeQur News & Media
CeQur® Announces Exciting Advancements: 2 Recent FDA Clearances and New Clinical Evidence to be Presented at ADA
Extended 7-Day Wear and 1-Unit Dosing Clearances, and Two ADA Posters Signal a New Standard for Mealtime Insulin Management HORW, Switzerland, June 4, 2026 /PRNewswire/ -- CeQur®, the company dedicated to simplifying mealtime insulin delivery for people living with diabetes, today...CeQur raises $120M to support insulin delivery tech - MassDevice
Insulin delivery technology developer CeQur today announced a significant funding round to support its commercialization efforts.CeQur Appoints Rick Doubleday and Dr. Meret Gaugler to Board of Directors
LUCERNE, Switzerland & MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #CeQur--CeQur®, a medical device company committed to simplifying the lives of people with diabetes by revolutionizing insulin-delivery solutions, today announced the appointments of Rick Doubleday and Meret Gaugler, Ph.D., to its Board of Directors. “Rick and Meret are exceptional leaders with an incredible depth of healthcare experience, and I am thrilled to welcome them to CeQur’s Board of Directors,” said Richard Mott, Chair, CeQur
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CeQur
Sign Up For FreeTo access detailed company insights
CeQur is commercializing advanced, simple-to-use insulin-delivery devices that make it easier for people living with diabetes to adhere to therapy and stay in control of their disease. Established in 2008, CeQur is headquartered in Switzerland.... Read More
